State of the M&A Market: The Divestiture Paradox
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/state-of-the-ma-market-the-divestiture-paradox",
"featuredImage": "https://cdn2.hubspot.net/hubfs/2661279/Imported_Blog_Media/jpeg-6.jpeg",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5634049305,
"post_summary": "<p>One may anticipate a spike in corporate divestitures immediately following a period of significant economic decline as companies pull back the reigns and focus on reducing non-core / under-performing units. Similarly, one may also expect activity to decline in the years following as businesses right-size the ship and transition into a more stable market. Oddly enough, these expectations were contradicted in the years surrounding the 2008 financial crisis. Divestiture activity for the five year period prior to the crisis depicted consistent expansion with annual growth of ~ 3%, but revealed a change once the crisis set in. Activity constricted by ~ 2% between 2008 and 2009 while companies accessed what to do next, but then started on an upward trajectory with growth of nearly 7% per year thereafter through first half of 2014. In the five year period (06/09 to 06/14), divestitures increased by nearly 40% from 2,500 per year to 3,500.</p> \n",
"title": "State of the M&A Market: The Divestiture Paradox",
"topicNames": [
"Articles",
"Hide Date",
"Banking, Finance & Insurance",
"M&A"
]
}A Prescription for M&A – Compound Pharmacies Face Change
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/a-prescription-for-ma-compound-pharmacies-face-change",
"featuredImage": "",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5634047806,
"post_summary": "<p>The compounding pharmacy industry is ripe for consolidation and many anticipate a pickup in M&A activity. As compounding pharmacist head to Washington, DC to attend the industry insiders “IACP’s 20th Compounders on Capitol Hill 2014” summit later this month, it is worthwhile to provide insight on this subsector.</p> \n",
"title": "A Prescription for M&A – Compound Pharmacies Face Change",
"topicNames": [
"Articles",
"healthcare",
"Hide Date",
"M&A"
]
}Props
{
"defaultContent": {
"nextPage": "Next page",
"previousPage": "Previous page"
},
"defaultRules": {
"lockHeadingTextField": true
},
"dataQueryResult": {},
"fieldValues": {
"defaultContent": {
"nextPage": "Next page",
"previousPage": "Previous page"
},
"defaultRules": {
"lockHeadingTextField": true
}
},
"hublParameters": {
"field_types": {
"defaultContent": "group",
"defaultRules": "group"
},
"is_widget_block": true,
"module_id": 209876701002,
"org_tag": "module_block",
"parent_widget_container": "main",
"path": "@projects/react-theme-huzaifa/theme/components/modules/BlogListing",
"smart_type": "NOT_SMART",
"widget_type": "module",
"wrap_field_tag": "div"
},
"hublData": {
"blogPostIds": [
5634049305,
5634047806
],
"blogPosts": [
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/state-of-the-ma-market-the-divestiture-paradox",
"featuredImage": "https://cdn2.hubspot.net/hubfs/2661279/Imported_Blog_Media/jpeg-6.jpeg",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5634049305,
"post_summary": "<p>One may anticipate a spike in corporate divestitures immediately following a period of significant economic decline as companies pull back the reigns and focus on reducing non-core / under-performing units. Similarly, one may also expect activity to decline in the years following as businesses right-size the ship and transition into a more stable market. Oddly enough, these expectations were contradicted in the years surrounding the 2008 financial crisis. Divestiture activity for the five year period prior to the crisis depicted consistent expansion with annual growth of ~ 3%, but revealed a change once the crisis set in. Activity constricted by ~ 2% between 2008 and 2009 while companies accessed what to do next, but then started on an upward trajectory with growth of nearly 7% per year thereafter through first half of 2014. In the five year period (06/09 to 06/14), divestitures increased by nearly 40% from 2,500 per year to 3,500.</p> \n",
"title": "State of the M&A Market: The Divestiture Paradox",
"topicNames": [
"Articles",
"Hide Date",
"Banking, Finance & Insurance",
"M&A"
]
},
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/a-prescription-for-ma-compound-pharmacies-face-change",
"featuredImage": "",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5634047806,
"post_summary": "<p>The compounding pharmacy industry is ripe for consolidation and many anticipate a pickup in M&A activity. As compounding pharmacist head to Washington, DC to attend the industry insiders “IACP’s 20th Compounders on Capitol Hill 2014” summit later this month, it is worthwhile to provide insight on this subsector.</p> \n",
"title": "A Prescription for M&A – Compound Pharmacies Face Change",
"topicNames": [
"Articles",
"healthcare",
"Hide Date",
"M&A"
]
}
],
"currentPageNumber": 10,
"nextPageNumber": 11,
"previousPageNumber": null,
"totalPageCount": 51,
"use_featured_image_in_summary": true
},
"experimentalHublData": null,
"moduleName": "main-module-2",
"supplementalFieldValues": {
"defaultContent": {
"nextPage": {},
"previousPage": {}
},
"defaultRules": {
"lockHeadingTextField": {}
}
}
}